|
MTMR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.279000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.212000E-01 |
| Normal-vs-Stage2 |
6.919400E-01 |
| Normal-vs-Stage3 |
7.176600E-01 |
| Normal-vs-Stage4 |
7.942800E-01 |
| Stage1-vs-Stage2 |
6.489600E-01 |
| Stage1-vs-Stage3 |
4.568600E-01 |
| Stage1-vs-Stage4 |
5.132000E-01 |
| Stage2-vs-Stage3 |
9.266800E-01 |
| Stage2-vs-Stage4 |
8.842800E-01 |
| Stage3-vs-Stage4 |
9.508000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.021600E-01 |
| Normal-vs-AfricanAmerican |
3.067200E-01 |
| Normal-vs-Asian |
3.288600E-01 |
| Caucasian-vs-AfricanAmerican |
5.940200E-01 |
| Caucasian-vs-Asian |
7.950000E-01 |
| AfricanAmerican-vs-Asian |
7.563400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.547800E-01 |
| Normal-vs-Female |
2.060800E-01 |
| Male-vs-Female |
2.058200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.674370E-01 |
| Normal-vs-Age(41-60Yrs) |
8.117400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.875400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.301600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.806400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.053000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.667580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.196400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.178200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.156000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.668600E-01 |
| Classical-VS-Follicular |
1.075790E-01 |
| Classical-VS-Other |
3.615400E-01 |
| Classical-VS-Normal |
1.011570E-01 |
| Tall-VS-Follicular |
5.971800E-01 |
| Tall-VS-Other |
4.914600E-01 |
| Tall-VS-Normal |
5.337000E-01 |
| Follicular-VS-Other |
7.587800E-01 |
| Follicular-VS-Normal |
9.792400E-01 |
| Other-VS-Normal |
6.448800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.568800E-01 |
| Normal-vs-N1 |
9.958200E-01 |
| N0-vs-N1 |
8.134400E-01 |
|
|
